🌍 How can joint scientific consultations reshape the future of health technology in Europe?

The European Commission’s new regulation on joint scientific consultations under the Health Technology Assessment (HTA) Regulation offers a structured pathway for health technology developers to gain early insights on the clinical evidence required for assessments.

This initiative is set to enhance efficiency, foster collaboration, and ultimately improve patient access to innovative therapies.

Jump into the implications of this regulation for the healthcare landscape!

#SyenzaNews #HealthTechnology #HealthcareInnovation #MarketAccess

💡 *Are we getting the most value from our cancer treatments? *
A new study reveals that imatinib is the most cost-effective treatment option for chronic myeloid leukemia (CML) in South Africa, outperforming nilotinib and dasatinib both in costs and quality-adjusted life years (QALYs). This analysis emphasises critical implications for the South African healthcare system, emphasising the need for price negotiations to enhance treatment access.

Explore the findings and their impact on healthcare policy and resource allocation.

#SyenzaNews #HealthEconomics #CostEffectiveness #HealthcarePolicy

💭 Are we doing enough to address ethnic disparities in endometrial cancer mortality?
A recent study highlights alarming trends in endometrial cancer mortality rates in South Africa, where rates have nearly doubled from 1999 to 2018, with significant variations among different ethnic groups. Understanding these disparities is crucial for developing targeted public health strategies to improve outcomes.

Look into the full article to explore the key insights and implications for healthcare policy and intervention strategies.

#SyenzaNews #globalhealth #healthcarepolicy